Cargando…
Pathogen Reduction for Platelets—A Review of Recent Implementation Strategies
The development of pathogen reduction technologies (PRT) for labile blood components is a long-pursued goal in transfusion medicine. While PRT for red blood cells and whole blood are still in an early phase of development, different PRT platforms for plasma and platelets are commercially available a...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879285/ https://www.ncbi.nlm.nih.gov/pubmed/35215085 http://dx.doi.org/10.3390/pathogens11020142 |